INVO Fertility Announces a 1:8 Reverse Stock Split Effective Pre-Market Opening on November 28, 2025

Core Viewpoint - INVO Fertility, Inc. will implement a 1-for-8 reverse stock split effective November 28, 2025, to enhance its stock price and maintain compliance with Nasdaq listing requirements [1][2]. Company Overview - INVO Fertility is a healthcare services company focused on the fertility market, particularly in expanding assisted reproductive technology (ART) care [3]. - The company's strategy includes building, acquiring, and operating fertility clinics, specifically "INVO Centers" that offer the intravaginal culture (IVC) procedure using the proprietary INVOcell medical device [3]. - INVO Fertility currently operates two INVO Centers and one IVF clinic in the United States and distributes the INVOcell technology to third-party fertility clinics [3]. - The IVC procedure is designed to provide a more natural, intimate, and cost-effective alternative to traditional IVF, with comparable results at a lower cost [3].